Royce & Associates LP Has $18.92 Million Holdings in Core Laboratories Inc. (NYSE:CLB)

Royce & Associates LP grew its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 9.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,021,121 shares of the oil and gas company's stock after purchasing an additional 84,022 shares during the period. Royce & Associates LP owned about 2.17% of Core Laboratories worth $18,921,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in CLB. Louisiana State Employees Retirement System boosted its position in Core Laboratories by 2.2% during the second quarter. Louisiana State Employees Retirement System now owns 23,600 shares of the oil and gas company's stock valued at $479,000 after purchasing an additional 500 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Core Laboratories by 3.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 18,054 shares of the oil and gas company's stock valued at $366,000 after buying an additional 579 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of Core Laboratories by 11.9% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company's stock valued at $114,000 after buying an additional 600 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Core Laboratories by 1.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 54,310 shares of the oil and gas company's stock worth $1,102,000 after buying an additional 758 shares during the last quarter. Finally, Signaturefd LLC raised its position in Core Laboratories by 12.8% during the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company's stock valued at $137,000 after acquiring an additional 767 shares in the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Stifel Nicolaus boosted their target price on shares of Core Laboratories from $18.00 to $22.00 and gave the stock a "hold" rating in a research report on Friday, July 26th. Citigroup decreased their price objective on shares of Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a report on Thursday, October 31st. Finally, StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $17.00.

Core Laboratories Stock Performance

Shares of NYSE:CLB traded down $0.42 during trading on Friday, reaching $19.53. The stock had a trading volume of 293,695 shares, compared to its average volume of 425,366. The stock has a fifty day simple moving average of $18.91 and a two-hundred day simple moving average of $19.26. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. Core Laboratories Inc. has a 52 week low of $13.82 and a 52 week high of $25.13. The firm has a market capitalization of $916.93 million, a price-to-earnings ratio of 30.05, a P/E/G ratio of 1.40 and a beta of 2.35.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.21 by $0.04. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The business had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. During the same period last year, the business posted $0.22 EPS. Core Laboratories's revenue was up 7.2% compared to the same quarter last year. As a group, analysts anticipate that Core Laboratories Inc. will post 0.77 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 25th. Investors of record on Monday, November 4th will be given a dividend of $0.01 per share. The ex-dividend date is Monday, November 4th. This represents a $0.04 annualized dividend and a dividend yield of 0.20%. Core Laboratories's dividend payout ratio is presently 6.15%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.